William Gillen, MD
MOHS-Micrographic Surgery · Richmond, VANPI 1932460441
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 37.0% of the total. Reporting peaked in 2021 at $638 and has fallen 51.9% since, to $307 in 2025.
Across 109 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$762
- Johnson & Johnson$179
- Lilly USA, LLC$167
- Genentech USA, Inc.$163
- Regeneron Healthcare Solutions, Inc.$110
- LEO Pharma Inc.$82
- plus $597 from 12 others
What the payments were for
- Food & beverage$2,061100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $762 |
| Johnson & Johnson | 13 | $179 |
| Lilly USA, LLC | 8 | $167 |
| Genentech USA, Inc. | 8 | $163 |
| Regeneron Healthcare Solutions, Inc. | 5 | $110 |
| LEO Pharma Inc. | 5 | $82 |
| Novartis | 4 | $79 |
| Galderma Laboratories, L.p. | 5 | $77 |
| Sanofi | 3 | $70 |
| UCB, Inc. | 3 | $65 |
| Organogenesis Inc. | 3 | $63 |
| Sun Pharmaceutical Industries Inc. | 4 | $62 |
| EPI Health, LLC | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| Amgen | 1 | $30 |
| Incyte Corporation | 1 | $27 |
| Almirall LLC | 1 | $25 |
| Dermira, Inc. | 1 | $17 |
How this compares
$2,061 in reported general payments places this provider in the 60th percentile of 36 mohs-micrographic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 65 | $2,527 |
| Cephalexin | 338 | $1,805 |
| Cefdinir | 75 | $1,001 |
| Fluorouracil | 11 | $880 |
| Doxycycline Hyclate | 46 | $364 |
| Clindamycin Hcl | 65 | $329 |
| Mupirocin | 23 | $216 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $127 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Richmond
- Matthew WallaceRichmond$4K
- Brian JohnsonNorfolk$16K
- Sherry MaraghAshburn$12K
- Kristin BibeeCharlottesville$11K
- Kenneth NealArlington$9K
- James BotaNorfolk$9K
- Brian JohnsonNorfolk$5K
- Soonyou KwonVienna$4K
- Amir BajoghliMc Lean$4K
- Jeffrey ScottFairfax$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.